SURINPARK: Safinamide for Urinary Symptoms in Parkinson's Disease.

Brain Sci · 2021 · PMC7825064 · PMID 33418858

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Safinamide (SA+) patients showed a trend towards a more advanced disease in their basal features, as expected, as the drug is labeled as an add-on to levodopa in fluctuating disease.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.